Dasatinib Drugs Market, By Type (20 mg, 50 mg, and 70 mg), By Indication (Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America

Dasatinib Drugs Market, By Type (20 mg, 50 mg, and 70 mg), By Indication (Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Dasatinib is a potential tyrosine kinase inhibitor that has revolutionized the treatment landscape for certain types of cancer. Initially developed as a targeted therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), dasatinib specifically targets and inhibits the BCR-ABL protein, suppressing the growth and proliferation of cancer cells. With remarkable efficacy, dasatinib has significantly improved outcomes and increased survival rates in patients with these malignancies. Moreover, dasatinib exhibits inhibitory effects on other tyrosine kinases, including SRC family kinases, broadening its potential application to various tumors. While dasatinib offers a promising therapeutic option, it is not without side effects, necessitating careful monitoring and management. Ongoing research and clinical trials are exploring the potential of dasatinib in combination therapies, paving the way for further advancements in cancer treatment strategies.

Market Dynamics:

The increasing prevalence of cancer, favorable clinical outcomes, and expansion of approved indications are anticipated to drive the growth of the global dasatinib drugs market over the forecast period. Moreover, the development of targeted therapies is also expected to boost the growth of the global dasatinib drugs market over the forecast period. Expansion into emerging markets, combination therapies, pediatric indications, and the development of generic versions are expected to create growth opportunities for the global dasatinib drugs market growth during the forecast period.

However, the high cost of treatment, stringent regulatory requirements, potential adverse effects, the development of resistance are expected to hamper the growth of the dasatinib drugs market over the forecast period.

Key features of the study:
  • This report provides an in-depth analysis of the global dasatinib drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global dasatinib drugs market based on the following parameters – company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bristol-Myers Squibb Company, MSN Labs, Lupin, Dr. Reddy’s Laboratories, Gilead Sciences, Inc., Hetero Labs, MANUS AKTTEVA BIOPHARMA LLP, Alembic Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., and Zhejiang Hisun Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global dasatinib drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dasatinib drugs market
Detailed Segmentation:
  • Dasatinib Drugs Market, By Type:
  • 20 mg
  • 50 mg
  • 70 mg
  • Dasatinib Drugs Market, By Indication:
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Others
  • Dasatinib Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Dasatinib drugs market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles:
  • Bristol-Myers Squibb
  • MSN Labs
  • Lupin
  • Dr. Reddy’s Laboratories
  • Hetero Labs
  • MANUS AKTTEVA BIOPHARMA LLP
  • Alembic Pharma
  • JINLAN Pharm-Drugs Technology Co., Ltd.
  • Reddy's Laboratories
  • Zhejiang Hisun Pharma


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Indication
Market Snippet, By Distribution channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing prevalence of cancer
Restraints
Increasing product recall
Opportunities
Expansion into emerging markets
Combination therapies
Pediatric indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Dasatinib Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Dasatinib Drugs Market, By Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
20 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
50 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
70 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Dasatinib Drugs Market, By Indication, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Chronic Myeloid Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Acute Lymphoblastic Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Dasatinib Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Dasatinib Drugs Market, By Region, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2019 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
North Africa
South Africa
Central Africa
9. Competitive Landscape
Bristol-Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
MSN Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hetero Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Alembic Pharma,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
JINLAN Pharm-Drugs Technology Co., Ltd.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Reddy's,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Zhejiang Hisun Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 35 market data tables and 30 figures on "Dasatinib Drugs Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings